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Abstract
Background: BMP6 mediated osteoblast differentiation plays a key role in skeletal development and bone disease.
Unfortunately, the signaling pathways regulated by BMP6 are largely uncharacterized due to both a lack of data
and the complexity of the response.
Results: To better characterize the signaling pathways responsive to BMP6, we conducted a time series microarray
study to track BMP6 induced osteoblast differentiation and mineralization. These temporal data were analyzed
using a customized gene set analysis approach to identify temporally coherent sets of genes that act downstream
of BMP6. Our analysis identified BMP6 regulation of previously reported pathways, such as the TGF-beta pathway.
We also identified previously unknown connections between BMP6 and pathways such as Notch signaling and the
MYB and BAF57 regulatory modules. In addition, we identify a super-network of pathways that are sequentially
activated following BMP6 induction.
Conclusion: In this work, we carried out a microarray-based temporal regulatory pathway analysis of BMP6
induced osteoblast differentiation and mineralization using GAGE method. This novel temporal analysis is more
informative and powerful than the classical static pathway analysis in that: (1) it captures the interconnections
between signaling pathways or functional modules and demonstrates the even higher level organization of
molecular biological systems; (2) it describes the temporal perturbation patterns of each pathway or module and
their dynamic roles in osteoblast differentiation. The same set of experimental and computational strategies
employed in our work could be useful for studying other complex biological processes.
Background
Osteoblasts are responsible for bone matrix production
and mineralization [1]. In concert with osteoclasts, osteo-
blasts coordinate bone remodeling, a physiologic process
by which bone mass is maintained [1]. Osteoblasts arise
from mesenchymal stem cells (MSC) [1]. However, the
mechanism controlling this differentiation process is not
well understood.
MSC differentiation to osteoblasts can be induced
both in vivo and in vitro by soluble factors in the bone
morphogenetic protein family (BMP) [2,3]. Among the
BMPs, BMP2, 4, 6 and 7 are the best characterized ose-
togenic factors [4]. Our previous work [5] has shown
that: (1) human MSC produce BMP6 in defined, serum-
free conditions, (2) BMP6 is up-regulated under mild
osteogenic stimulus (dexamethasone), (3) exogenous
BMP6 potently induces osteoblast differentiation, but
responses to BMP2, 4, or 7 are inconsistent and require
higher doses, (4) exogenous BMP6 induces the expres-
sion or up-regulation of a set of osteoblast-related genes
in human MSC, and (5) 24 hour treatment with BMP6
induce high levels of osteoblast gene expression and
cause mineralization. These results established BMP6 as
an endogenous regulator of human osteoblast differen-
tiation [5].
Unfortunately, BMP6 signaling largely remains unchar-
acterized. Significant efforts, particularly a series of high
throughput microarray studies [6-12] have been
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undertaken to uncover BMP (including BMP6) respon-
sive genes, transcriptional programs, and their roles in
osteoblast development. However, an integrated under-
standing of the regulatory mechanisms for osteoblast dif-
ferentiation and mineralization has not been achieved. In
particular, two remaining questions include: (1) what
pathways and gene groups are responsible for MSC dif-
ferentiation to osteoblasts in response to BMP6 stimula-
tion? (2) what is the sequence of pathway activation
events in response to BMP6 during the osteogenic
induction?
To answer these two questions, we conducted a time
series microarray study on BMP6 osteogenic induction
and a comprehensive pathway analysis on the temporal
data. We met special challenges at both experiment and
data analysis levels.
At experiment level, we considered two major issues.
First, what rate to sample the time series? The time inter-
vals should be short enough to capture the dynamics and
continuity, but long enough to show phenotypically sig-
nificant changes. We determined time intervals based on
the minimal BMP6 treatment durations needed for sig-
nificant phenotypic changes, including the expression of
osteoblast markers and formation of mineralized extra-
cellular matrix (Figure 1). Second, given that osteoblast
induction is a temporal process with accumulative effects
and gradual changes, how to dissect out the net effect of
BMP6 at different phenotypic stages? We employed a
BMP6 addition-and-withdrawal scheme (Figure 1).
At data analysis level, we developed a novel temporal
pathway analysis procedure. Gene set analysis (GSA) is
a well established strategy to identify pathways or gene
sets associated with a particular phenotype or condition
[13-16]. Temporary analysis was done on biological pro-
cesses previously [17]. However, traditional GSA meth-
ods do not directly apply without externally specified
selection criteria for temporal changes. Methods like
GSEA [13] accept continuous phenotype labels hence
can correlate gene set changes to time or pre-defined
temporal patterns. To our knowledge, these methods do
not infer temporal pathway level changes without refer-
ence patterns. For such temporal pathway analysis to be
practical, a method needs to be: (1) applicable to data-
sets with small or even changing sample size at each
time point or condition. (2) both sensitive and selective
to capture subtle yet real regulatory signals over time.
To meet these challenges, we designed a special analysis
procedure (Figure 1) based on our newly developed
GAGE (Generally Applicable Gene-set Enrichment)
method [18].
Using this joint experimental and computational
approach, we identified both the pathways and their
Figure 1 Design for the microarray study on BMP6 induced osteoblast differentiation. Human MSC cells were pre-cultured for 4 days and
subsequently treated with BMP6 for 0 hours, 8 hours, 24 hours, and 96 hours. These four time points correspond to four phenotypic groups, of
control, preosteoblast (no mineralization), (sub-maximal) mineralization, and maximal mineralization at 14 days (18 days in total). Cells were
harvested at 8 hours, 24 hours, 96 hours and 10 days for microarray profiling. Mineralization level was quantified at 14 days by Alizarin Red S
staining (right column). GAGE was applied to infer the most differentially expressed pathways or gene sets between the matched samples with
or without BMP6 at different time points. At time points corresponding to 8, 24 and 96 hours, GAGE compares between only two sample
conditions. At the 10 day time point, GAGE compares between two mineralized conditions versus two non-mineralized conditions.
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temporal responses to BMP6 signaling during osteoblast
differentiation and mineralization.
Results
Following our previous study [5], we explored BMP6
induced human MSC osteoblast gene expression and
function. Our preliminary experiments showed that
8 hours BMP6 exposure was sufficient to induce expres-
sion of osteoblast differentiation marker genes in human
MSCs. A minimum of 24 hours exposure was required
to form mineralized matrix at 14 days after the initiation
of BMP treatment. A maximal mineralization response
was observed upon 96 hours of BMP6 treatment.
We designed a microarray study to explore the regula-
tory mechanisms underneath these phenotypic changes at
different stages of human MSC osteoblast differentiation
(Figure 1). Our recently developed GAGE method [18] was
applied to infer the significantly perturbed KEGG (Kyoto
Encyclopedia of Genes and Genomes) pathways, GO
(Gene Ontology) term groups, and experimentally derived
gene sets (experimental sets for short) by BMP6 treatment
at different times along the induction process (Figure 1).
We examined these significant gene sets in details below.
Significantly perturbed KEGG pathways during BMP6
osteogenic induction
We observed a single set of KEGG pathways that were sig-
nificantly perturbed at the gene expression level
throughout the BMP6 induction process (Figure 2F and
Table 1). This result suggests that these regulatory
mechanisms are constantly involved at different stages of
BMP6 induced osteoblast differentiation and mineraliza-
tion. To test whether a KEGG pathway are significantly
associated with a phenotype or a sample condition, we
account for gene expression level perturbation in both
directions (both up- and down-regulation), because a
pathway commonly includes both positive and negative
effectors and local feedback loops to keep the system in
balance [18]. Therefore, we refer to a KEGG pathway as
significantly perturbed rather than activated or inhibited
as a whole.
These significant KEGG pathways show different tem-
poral perturbation patterns (Figure 2). The TGF-beta sig-
naling pathway, Cytokine-cytokine receptor interaction,
and Wnt signaling pathway are most perturbed at 8h. The
Jak-STAT signaling pathway, MAPK signaling pathway
and p53 signaling pathway are most perturbed at 24h.
Focal adhesion and ECM-receptor interaction are most
perturbed at 10d.
We explored the pattern of differential gene expres-
sion induced by BMP6 treatment in three representative
pathways in detail (Figure 3 a-c and Additional file
1,2,3,4,5). First, TGF-beta signaling pathway is the top
significant pathway (compared to other pathways) at 8h
and is most perturbed (compared to itself at other time
points) also at 8h. Therefore, this pathway is likely
Figure 2 The expression perturbation patterns induced by BMP6 treatment in eight significant KEGG pathways. These pathways are
consistently significantly differentially expressed or near so based on GAGE. The mean t-statistics from multiple one-on-one comparisons between
the two sample conditions is used as overall perturbation magnitude for each pathway. Perturbation magnitude here is defined as the absolute
value of both positive and negative gene expression changes without considering the actual perturbation direction. The dashed line indicates a t-
statistic of 1.79, which roughly corresponds to p = 0.01 for 8-96 h or 0.001 for 10 d. Panel (a) and (b) are divided only for visual clarity.
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triggered directly by BMP6 treatment, and could be the
signal initiating the osteoblast differentiation. This role
of TGF-beta signaling is consistent with previous work
[19] and the common sense: BMP6 as a canonical BMP
triggers canonical BMP signaling, which is one major
branch of TGF-beta signaling pathway. Second, focal
adhesion is the most significant pathway (compared to
other pathways) after 24h and is most perturbed (com-
pared to itself at other time points) at 10 days. This
pathway is likely the convergence point of the regulatory
signals, and it is associated with late stage osteoblast dif-
ferentiation and mineralization. These results are consis-
tent with the role of focal adhesion inferred from
experimental work in the literature [20,21]. Third, the
Table 1 Interpretation and validation of the significant KEGG pathways inferred by GAGE.
KEGG pathways Most perturbed References Other evidences
TGF-beta signaling pathway 8h [5,57] BMP signal targets IDs, SMAD6-7, DLX5 extremely up
Cytokine-cytokine receptor interaction 8h [33,58] IFN target gene sets down (Table 4)
Wnt signaling pathway 8h [59,60]
Jak-STAT signaling pathway 24h [58,61] STAT1 target genes down
MAPK signaling pathway 24h [22,23] –
p53 signaling pathway 24h [62,63] –
Focal adhesion 10d [20,21] –
ECM-receptor interaction 10d [64,65] –
Literature findings and experimental evidence suggest regulatory roles of these KEGG pathways in BMP6 induced osteoblast differentiation and mineralization.
Figure 3 Gene expression fold changes induced by BMP6 in three representative significant KEGG pathways. Each pathway shown is at
its most perturbed time point: (a) TGF-beta signaling pathway at 8h; (b) Focal adhesion at 10d; (c) MAPK signaling pathway at 24h. Gene
expression level fold changes are standardized over the standard deviation of fold changes for all genes. The standardized fold changes are
visualized by using KEGGanim web tool [56]. Note that one KEGG node may correspond to multiple closely related genes with the same
function. Relevant other pathways are magnified locally for better view. Gene names are intentionally omitted by KEGGanim for clear view of the
gene expression changes in pseudo-color.
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MAPK signaling pathway is the most perturbed at 24h
or the middle stage of differentiation, which suggests
that this pathway is likely an intermediate step during
the BMP6 induced signal relay process at gene expres-
sion level. Indeed, MAPKs have been reported to med-
iate BMP effect during osteoblast differentiation [22,23].
The temporal perturbation patterns in other significant
pathways suggest their functions in the BMP6 induction
process, which are supported by both observations in
the literature and evidence from the expression data
(Table 1). The temporal roles assigned to the pathways
are relative, because all these pathways are important
throughout BMP6 induced osteoblast differentiation and
mineralization (Figure 2).
Interestingly, the significant KEGG pathways are not
distinct but rather act as an integrated super regulatory
system. They interconnect to each other as shown on
KEGG pathway graphs (Figure 3a-c). For example, the
TGF-beta pathway triggers the MAPK signaling path-
way (Figure 3a), whereas MAPK signaling pathway
connects to focal adhesion (Figure 3b). These pathways
also share common downstream response processes
including apoptosis, cell cycle etc (Figure 3a-c). Using
the top KEGG pathways inferred by GAGE [18], gene
expression data and connections between pathways
from LinkDB module of KEGG databases [24], we cre-
ated an integrated dynamic network view of pathways
in Figure 4. The upstream nodes including TGF-beta
signaling pathway and cytokine-cytokine receptor
interaction are most perturbed at the early stage.
Downstream nodes including focal adhesion and ECM-
receptor interaction are most perturbed at the late
stage. Midstream nodes including MAPK signaling and
p53 signaling are most perturbed at the middle stage.
These sequential perturbation patterns across intercon-
nected pathways suggest a dynamic transmission pro-
cess of the regulatory signals induced by BMP6
treatment at the transcriptional level.
The connected significant pathways (Figures 4) often
share component genes that are evidently perturbed in
expression (Table 2). Particularly, overlaps between sig-
nificant KEGG pathways (Table 2) are consistent with
the connections between pathways (Figure 4): high over-
laps (Table 2) almost always suggest direct connections
between pathways (Figure 4), and vise versa. Overlap-
ping component genes serve as bridges across these
relatively independent functional modules or pathways,
hence perturbation in one pathway such as the BMP-
TGF-beta signaling pathway can be propagated through-
out other relevant pathways. These data suggest that
these significant KEGG pathways work together as an
integrated regulatory system.
Significantly perturbed GO term gene sets during BMP6
osteogenic induction
In contrast to the top KEGG pathways, the top signifi-
cant GO term gene sets change with time (Figure 5 and
Table 3). Most relevant GO term gene sets are signifi-
cantly up or down regulated only for part of the induc-
tion process, except for the Notch signaling pathway
and insulin-like growth factor receptor binding. In con-
trast to the KEGG pathways, where we test for two-
directional perturbations, we test for one-directional
changes in GO term gene sets as a complementary ana-
lysis to the KEGG pathway analysis above. More details
are described in the Methods section. Additional file 6
includes comprehensive lists of significant KEGG path-
ways and GO groups at different time points.
The top GO term gene sets suggest novel yet plausible
regulatory processes involved in BMP6 induced osteo-
blast differentiation and mineralization. Some GO terms
are self-explaining, including skeletal development and
ossification (Figure 5b). Other less evident top GO terms
are supported by the literature (Table 3). For example,
the notch signaling pathway (Figure 5a) is directly
involved in BMP2 induced osteoblast differentiation
[11,25], suggesting a possible connection to BMP6 too.
Both insulin-like growth factor receptor binding and
insulin-like growth factor binding (Figure 5a) suggest
that the IGF signal is important for osteoblast differentia-
tion and mineralization. Indeed IGF1 [26] and IGF1R
[27] promote mineralization and bone formation,
whereas IGFBP 3-6 [28-31] sequesters IGF1 and inhibits
osteoblast differentiation and mineralization. Direct con-
nections between immune response (Figure 5b) and bone
formation and metabolism have been well appreciated
[32,33], which merge into a new research area, osteoim-
munology [33]. Genes from homophilic cell adhesion
[34] and oxidoreductase activity [35] (Figure 5b) sets play
a role in osteoblast differentiation. Selenium (Figure 5a)
deficiency is associated with osteoporosis [36], a disease
in bone formation and metabolism.
Significantly perturbed experimentally derived gene sets
during BMP6 osteogenic induction
Our analysis also identified the most significantly up or
down-regulated experimental sets during BMP6 induc-
tion. Experimental sets are gene groups coregulated or
coexpressed in certain chemical or genetic perturbation
experiments from the literature. A significant experi-
ment set suggests that their common regulator was per-
turbed in our experiment too. There are commonly
multiple experimental sets describing the same pertur-
bation or mapping to the same regulatory mechanism.
A non-redundant subset of the top experimental sets
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were collected in Table 4 with their perturbation pat-
terns shown in Figure 6. Similar to gene sets based on
GO terms but not to those on KEGG pathways, experi-
mental sets were tested for perturbations in only one
direction, either up- or down- regulated [18].
MYB transcription factor is identified as a novel regu-
lator for osteoblast differentiation. MYB target gene set
was down regulated at 8h, 24h and 10d with no change
in MYB expression level. MYB transcriptional activity at
protein level can be inhibited through two potential
mechanisms following BMP6 treatment: the activation
of Wnt signaling pathways (Table 1 and Figure 2) phos-
phorylates and degrades of MYB protein [37], and BMP/
TGF-beta and Wnt responsive OVOL1 antagonizes
Figure 4 An integrated network of the significant KEGG pathways with their temporal perturbation patterns. Significant KEGG pathways
(colored pie charts) or closely related other pathways (text only) are connected by arrows as indicated in the KEGG database. The mean t-
statistics from multiple one-on-one comparisons at four different time points are plotted in pseudo heat color in the pie nodes as the average
perturbation magnitude for significant KEGG pathways. Full names for some abbreviated KEGG pathways are: Cytokine-cytokine receptor
interaction (Cytokine), Ubiquitin mediated proteolysis (Ublysis), Phosphatidylinositol signaling system (phosph).
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transcriptional activation of MYB by competing for tar-
get promoter binding [38].
Another novel transcriptional regulator for osteoblast
differentiation we predicted is BAF57, which is the regu-
latory subunit SWI/SNF chromatin remodeling complex
[39]. Multiple BAF57 target genes are directly related to
osteoblast differentiation and function (Additional file 1:
Supplementary Table 1). Indeed, SWI/SNF regulates
osteoblast-specific transcription through chromatin
structure modification [40]. BMP6 treatment may target
SWI/SNF to nucleus though SMAD1 signal [41] or p38
MAPK pathway targets SWI-SNF chromatin-remodeling
complex [42]. Interestingly, BAF57 positive target genes
are up-regulated and negative targets down-regulated
during BMP6 induction, which further confirms the
involvement of BAF57 activity. The different timing of
the positive and negative regulation likely suggests dif-
ferent dynamics of these actions.
Other interesting regulatory mechanisms are inferred
based on the top ranking experimental sets (Table 4).
Interferon beta (interferon alpha and gamma too, but
not shown) positive target gene sets are down-regulated,
Table 2 The overlaps in perturbed member genes between the significant KEGG pathways inferred by GAGE
TGFb Cyto Wnt MAPK Jak p53 Focal ECM
TGFb 0 (22) 5.6E-20(8) 3.3E-06(2) 4.3E-10(4) 3.1E-04(1) 3.1E-04(1) 2.9E-06(2) 4.1E-05(1)
Cyto 5.6E-20(8) 0(34) 1 (0) 3.4E-11(5) 8.3E-29(11) 1 (0) 6.4E-10(4) 1 (0)
Wnt 3.3E-06(2) 1 (0) 0 (24) 6.9E-10(4) 2.9E-06(2) 3.5E-09(3) 2.3E-08(3) 1 (0)
MAPK 4.3E-10(4) 3.4E-11(5) 6.9E-10(4) 0 (33) 7.0E-04(1) 2.7E-06(2) 5.5E-10(4) 1 (0)
Jak 3.1E-04(1) 8.3E-29(11) 2.9E-06(2) 7.0E-04(1) 0 (21) 1.4E-04(1) 3.4E-04(1) 1 (0)
p53 3.1E-04(1) 1 (0) 3.5E-09(3) 2.7E-06(2) 1.4E-04(1) 0 (15) 3.0E-09(3) 1.9E-05(1)
Focal 2.9E-06(2) 6.4E-10(4) 2.3E-08(3) 5.5E-10(4) 3.4E-04(1) 3.0E-09(3) 0 (23) 2.1E-24(7)
ECM 4.1E-05(1) 1 (0) 1 (0) 1 (0) 1 (0) 1.9E-05(1) 2.1E-24(7) 0 (8)
For each cell in the table, in the parenthesis is the number of perturbed member genes overlapping between the significant KEGG pathways; outside is the
significance of this overlap between KEGG pathways. Details of overlap analysis are given in Methods section. Full names for these KEGG pathways are: TGF-beta
signaling pathway (TGFb), Cytokine-cytokine receptor interaction (Cyto), Wnt signaling pathway (Wnt), MAPK signaling pathway (MAPK), Jak-STAT signaling
pathway (Jak), p53 signaling pathway (p53), Focal adhesion (Focal), ECM-receptor interaction (ECM).
Figure 5 The expression perturbation patterns induced by BMP6 treatment in nine significant GO term gene sets. Each of these GO
term gene sets is significant in at least one time point based on GAGE. (a) GO:0007219 Notch signaling pathway, GO:0005520 insulin-like growth
factor binding, GO:0005159 insulin-like growth factor receptor binding, GO:0008430 selenium binding, (b) GO:0007156 homophilic cell adhesion,
GO:0006955 immune response, GO:0001501 skeletal development, GO:0001503 ossification, GO:0016491 oxidoreductase activity. The mean t-
statistic from multiple one-on-one comparisons between the two sample conditions is used as a measure of the overall perturbation for each
GO term. Different from KEGG pathways, perturbation direction is considered here. The dashed lines mark t = +/-1.30, which roughly correspond
to p = 0.05 for 8-96 h or 0.01 for 10 d.
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which is consistent with Jak-STAT pathway from KEGG
(Table 1). VEGF positive targets are down-regulated,
likely because VEGF gene expression is down-regulated
due to MYB inhibition [43]. IRS negative targets are
down-regulated is consistent with activation of IGF sig-
nal, particularly up-regulation of IGF receptor binding
proteins (Table 4 and Figure 5).
Discussion and Conclusion
This is the first high throughput microarray study on
BMP6 induced transcriptional program in human MSC.
It covers the whole process from early to late stage
osteoblast differentiation and mineralization. We con-
ducted a comprehensive gene set analysis to identify
relevant regulatory mechanisms and functional groups.
We inferred a series of significant KEGG pathways, GO
terms and experimental sets at different stages of BMP6
induction process. We not only showed which pathways
or gene sets are significant, but also when and how they
are involved in the osteoblast differentiation and miner-
alization. Different from common pathway analyses
[13,14,16], our work further captures the interconnec-
tions among individual pathways or functional groups
and integrate them into a whole system. Taken together,
this work provides clearer mechanistic picture of osteo-
blast differentiation and function.
We inferred novel and coherent sets of regulatory
mechanisms downstream of BMP6 signaling during
osteoblast differentiation and mineralization. First, the
same set of KEGG pathways are constantly involved in
BMP6 induction. Their roles in osteogenic induction are
clarified based on their perturbation patterns and con-
nected to relevant discoveries in literature. These signifi-
cant KEGG pathways are not separated but rather they
work as a unified super regulatory system, and the path-
way perturbation patterns we derived reflect a dynamic
transmission process of the regulatory signal at tran-
scriptional level along the super system. Second, a vary-
ing set of GO processes and functional groups are
involved at different stage of BMP6 induced osteoblast
differentiation and mineralization. These suggest novel
yet plausible regulatory mechanisms, which are con-
nected to but have not directly and explicitly introduced
in literature works. Third, the most significant experi-
mental sets suggest novel transcriptional regulators
including MYB and BAF57, and regulatory pathways
consistent with predictions based on KEGG and GO
gene sets above.
Connections between KEGG pathways are evident as
shown in the super regulatory network of pathways (Fig-
ure 4 and Table 2). Perturbations propagate along the
super network at two levels: at protein level, the phos-
phorylation, binding, activation/inhibition events relay
along pathways and transmit into interconnected path-
ways, as stated by KEGG graphs (Figure 3); at transcrip-
tional level, gene expression perturbation propagates
through auto-regulatory (feedback and feed forward)
loops within pathways, and bridges into its neighbor
Table 3 Interpretation and validation information of the significant GO term gene sets inferred by GAGE
GO terms Perturbation References Other evidence
Notch signaling pathway 8h-10d up [11,25] –
insulin-like growth factor receptor binding 8h-10d up [26,27] –
insulin-like growth factor binding 10d down [28-31] –
homophilic cell adhesion 24h-96h up [34] –
immune response 96h-10d down [32,33] –
skeletal development 8h-96h up – –
ossification 96h-10d up – –
oxidoreductase activity 8h-24h, 10d down [35] –
selenium binding 96h-10d up – –
Temporal perturbation patterns (significantly perturbed time period and the direction), supportive literature and experimental evidence all suggest the regulatory
roles of these GO terms in BMP6 induced osteoblast differentiation and mineralization.
Table 4 Interpretation and validation information on the
significant experimental sets inferred by GAGE
Experimental
sets
Significant References Other evidences
MYB targets 8h-24h,10d
down




BAF57 up 24h-96h up [39-42] BAF57 down
IFNb up 8h,10d down – Jak-STAT signal
(KEGG)
VEGF up 10d down [43] MYB targets
IRS down 8h-10d down – IGF signal (GO)
Temporal perturbation patterns, supportive literature works and extra
experimental evidences all suggest the regulatory roles of these experimental
sets in BMP6 induced osteoblast differentiation and mineralization.
Experimental sets came from MSigDB [51] c2 collection, where the original
names for these significant gene sets are: Lei_MYB_Regulated_Genes,
BAF57_BT549_Dn, BAF57_BT549_Up; (B) Der_IFNB_Up,
VEGF_Mmmec_6hrs_Up, IRS_Ko_Adip_Up (down regulated by IRS since up-
regulated upon IRS knock down).
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pathways through the multiple component genes in
common, as suggested by our pathway analysis results
(Figure 4 and Table 2). Protein level transmission is fas-
ter, but transcriptional level transmission lasts longer
hence ensure the long term biological effects. These
longer lasting transcriptional effects are clearly evident
in our data as the gene expression levels were perturbed
long after the withdrawal of BMP6 treatment. The hard
wired KEGG pathways and interconnections between
them define how BMP6 signal triggers downstream pro-
grams (Figure 4).
There are also connections between BMP6 signal and
the processes/groups represented by GO terms and
experimental sets. For example, Notch signal and IGF
signal are involved in the whole induction process (Fig-
ure 5a) like all significant KEGG pathways (Figure 2). It
follows that these two signals should be also part of the
super regulatory system and interconnected with multi-
ple significant KEGG pathways of the network (Figure
4). This hypothesis is well supported by our data and lit-
erature: (1) Notch signal directly interacts with BMP sig-
nal. SMAD1 and NIC synergize to induce expression of
HEY1 and other Notch targets [44-46]. Indeed up-regu-
lation of HEY1 (and HEY2) requires continued BMP6
treatment by 96 hours (Additional file 1: Supplementary
Figure 4c). Besides this binding-synergy at protein level,
Notch ligand JAG1 expression is also up-regulated
directly by BMP6 (Additional file 1: Supplementary
Figure 4c). Notch also interacts with Wnt signal [47].
(2) Growth hormone (GH) signal [48] as part of cyto-
kine-cytokine receptor interaction (KEGG pathway
04060) and Jak-STAT pathways (KEGG pathway 04630)
are activated and by BMP signal (Figure 4) with GHR
up-regulated (Additional file 1: Supplementary Figure
4a-b), GH signal up-regulates (IGF1 and IRS1, Addi-
tional file 1: Supplementary Figure 4d) and activates IGF
signal in turn [48]. Connections between BMP signal
and the two predicted transcriptional regulators, MYB
and BAF57, are described above in the Results.
When examined together, we find a consistent picture
emerging from the lists of significant KEGG pathways,
GO terms, and experimental sets. For example, KEGG
focal adhesion and ECM receptor interaction pathways
(Table 1), GO homophilic cell adhesion (Table 3) and
extracellular matrix structural constituent (not shown)
groups consistently show the relevance of cell adhesion
and extracellular matrix in osteoblast differentiation and
mineralization. GO immune response groups (Table 3)
echoes KEGG cytokine-cytokine receptor interaction
pathway (Table 1). Similarly, significant experimental
target genes sets (Table 4) closely reflected changes in
the regulatory KEGG pathways (Table 1) or GO pro-
cesses/groups (Table 3).
Interestingly, there are discrepancies among the clus-
tering and the significant KEGG pathways, GO terms,
and experimental sets. For example, Notch signaling is
Figure 6 The expression perturbation patterns induced by BMP6 treatment in six significant experimental sets. Each of these
experimental sets is significantly up or down regulated in at least one time point based on GAGE. (a) MYB targets, BAF57 down, BAF57 up; (b)
IFNb up, VEGF up, IRS down. The mean t-statistics from multiple one-on-one comparisons between the two sample conditions is used as overall
perturbation for each gene set. Different from KEGG pathways, perturbation direction is considered here. The dashed lines mark t = +/-1.78,
which roughly correspond to p = 0.01 for 8-96 h or 0.001 for 10 d.
Luo et al. BMC Systems Biology 2011, 5:82
http://www.biomedcentral.com/1752-0509/5/82
Page 9 of 13
defined as both a KEGG pathway and a GO process.
This KEGG pathway is not significant (not shown) but
this GO process is (Figure 5). This discrepancy arises
from two sources: (1) different definitions, i.e. KEGG
pathways contain partially different set of genes from
corresponding GO processes. While KEGG pathways
tend to cover the whole homeostatic signal transmission
systems even across multiple transcriptional cycles, GO
usually covers one or multiple discrete steps or func-
tional groups for a process. KEGG and GO definitions
can be considered complementary and both provide
valuable gene sets for our analysis. (2) GAGE [18] treats
KEGG pathways and GO term gene sets differently:
genes under a GO term are taken as a group coregu-
lated towards a single direction, either all up or all
down regulated, whereas genes in a KEGG pathway are
frequently not coregulated and expression changes in
both directions are counted. Timing discrepancies exist
between experimental sets and corresponding KEGG
pathways. For example, IFN positive target sets (only
IFN beta shown) are not significant at 24-96 hours and
MYB target set not at 96 hours (Figure 6) while Jak-
STAT pathway and Wnt signaling pathway are signifi-
cantly perturbed all the time (Figure 2). This can be
explained by the fact that two-directional perturbation
treatment for KEGG pathway does not account for
direction or net effect of the perturbation, whether
inhibited, activated or no overall effect. In the other
hand, GO term analysis has no such issue, and IRS
negative set and corresponding GO IGF receptor bind-
ing group are both significant all the time.
In this work, we took a systems approach in studying
MSC differentiation. We combined experimental and
computational work to reconstruct a unified picture of
BMP6 signaling. The same set of experimental design
and computational approach could be used to study
other physiological and pathological processes, such as
the differentiation of other cell types or tumorogenesis.
Methods
Cell culture and BMP6 osteogenic induction
Passage 5 human MSC (5 × 105) were plated in 24-well
dishes and cultured for 3 days. The cells were subse-
quently placed in serum free media supplemented with
ITS for 24 hours. BMP6 was then added for the pre-
defined time periods and then removed as shown in Fig-
ure 1. To remove BMP6, cells were rinsed 2 times
before fresh media without BMP6 was added. Ascorbate
and b-glycerolphosphate were added 4 days after the
initiation of BMP treatment. Cells were harvested at the
indicated time points. To quantifying mineralization, the
plates were stained with Alizarin Red S [5] 14 days after
the initiation of BMP treatment.
Microarray experiment and analysis
Human MSC cells underwent osteogenic induction with
BMP6 treatment for 0 hours, 8 hours, 24 hours, and 96
hours, which correspond to four phenotypic groups, i.e.
control, preosteoblast (no mineralization), (sub-maximal)
mineralization, and maximal mineralization at 14 days
after the initiation of BMP treatment (18 days in total).
Cells were harvested at 8 hours, 24 hours, 96 hours and
10 days for microarray profiling using Affymetrix U133
plus GeneChip® platform. Assays were run in duplicate
for a total of 20 arrays.
The raw data were processed by using FRAMS [49]
with up-to-date probe set definition [44]. GAGE [18]
was applied to infer the most differentially expressed
pathways or gene sets between the BMP6 added or
withdrawn samples under comparison at different time
points (Figure 1). As is shown in Figure 1, the compari-
sons at 8, 24 and 96 hours were between two sample
conditions, whereas comparison at 10 days was between
the 24 and 96 hours BMP6 groups versus 0 and 8 hours
BMP6 groups.
Pathway analysis using GAGE
We use GAGE [18], Generally Applicable Gene set
Enrichment, a novel method we developed for gene set/
pathway analysis. The GAGE method is implemented in
R in the “gage” package, available through Bioconductor
at http://bioconductor.org/packages/release/bioc/html/
gage.html. As the GAGE procedure has been described
in detail in the original paper [18], here is a brief sum-
mary of the method.
Step 1: Gene sets separation. Gene sets are derived or
collected from KEGG pathways [24], GO [50] and
MSigDB [51] databases, as KEGG pathways, GO terms
and experimental sets respectively. GAGE treats KEGG
pathways differently from GO terms and experimental
sets: member genes for a GO term or experimental set
are taken as a group coregulated towards a single direc-
tion, either all up or all down regulated, whereas genes
in a KEGG pathway are frequently not coregulated and
expression changes in both directions are counted. We
test for one-directional changes in GO terms because
common function is frequently connected to coregula-
tion and coexpression [52,53], which has also been
extensively used in classical GO analysis tools [13,54,55].
Such treatment will miss some pathway-like GO terms
which are significantly perturbed in two directions, but
we intended to have GO analysis as a complementary
work to the KEGG pathway analysis. Nonetheless,
GAGE provides two-directional test options for all types
of gene sets. For GO analysis, all terms are included
without differentiating categories, i.e. Biological Process,
Cellular Component, Molecular Function, and without
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considering the hierarchical organization of the ontology
tree.
Step 2: One-on-one comparisons. Instead of compar-
ing BMP6 treated samples vs controls as two groups,
GAGE does one-on-one comparison between samples
from the two groups at a time. For each one-on-one
comparison, log based fold changes are calculated for all
genes. GAGE conducts two-sample t-test on the average
fold change in specific gene sets against that for the
background of the whole set. This one-on-one compari-
son procedure is repeated for all potential experiment-
control pairs.
Step 3: Summarization. For each gene set, GAGE
derives a global P-value based on a meta test on the
negative log sum of multiple P-values for this set from
all one-on-one comparisons between experiments and
controls.
Overlap between significant pathways
Significant KEGG pathways may overlap in terms of
perturbed member genes, which could suggest biologi-
cally meaningful connections between pathways. A gene
is counted as perturbed when its absolute fold change is
at least one standard deviation higher than the mean of
all genes. The significance of overlap between pathways
is inferred using hypergeometric test as following. Let n
represent number of perturbed genes in a pathway, N
number of all perturbed genes in a two-state compari-
son, x the overlap perturbed genes between pathways,
pathways 1 and 2 are labeled by corresponding suffix.
Then the chance to see X or more overlap perturbed
genes between two significant pathways is:















For significant KEGG pathways, we generated graphs to
visualize the dynamic expression perturbation at two
levels: individual genes (Figure 3 and Additional file
2,3,4,5) and whole pathways (Figure 4). Gene expression
level fold changes are standardized over the standard
deviation of fold changes for all genes. The standardized
fold changes for individual genes in KEGG pathways are
visualized by using KEGGanim web tool [56] in Figure 3
and Additional file 2,3,4,5. We present an integrated
network to show the connections between pathways and
average expression perturbations for them in Figure 4.
Significant KEGG pathways or closely related other
pathways connected to them are represented by nodes.
Connections between these pathways collected from
KEGG database and graphs [24] are represented by
arrows plus edges. The mean t-statistics from two-sam-
ple t-test from multiple one-on-one comparisons are
plotted in pseudo heat colors as average perturbation
magnitude for significant KEGG pathways.
Additional material
Additional file 1: Supplementary Tables and Figures.
Additional file 2: Supplementary Figure 1, animations of the
dynamic gene expression perturbation patterns in TGF-beta
signaling pathway.
Additional file 3: Supplementary Figure 2, animations of the
dynamic gene expression perturbation patterns in focal adhesion
pathway.
Additional file 4: Supplementary Figure 3, animations of the
dynamic gene expression perturbation patterns in MAPK signaling
pathway.
Additional file 5: the input pathway expression data, i.e.
standardized fold changes, used by KEGGanim web tool to
generated the KEGG Pathway plots in Figure 3.
Additional file 6: tables of significant KEGG pathways and GO
groups inferred by GAGE at different time points.
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